NZ626353A - Stabilized pharmaceutical formulations of a potent hcv inhibitor - Google Patents
Stabilized pharmaceutical formulations of a potent hcv inhibitorInfo
- Publication number
- NZ626353A NZ626353A NZ626353A NZ62635313A NZ626353A NZ 626353 A NZ626353 A NZ 626353A NZ 626353 A NZ626353 A NZ 626353A NZ 62635313 A NZ62635313 A NZ 62635313A NZ 626353 A NZ626353 A NZ 626353A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical formulations
- control
- stabilized pharmaceutical
- hcv inhibitor
- potent hcv
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000003389 potentiating effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000007857 degradation product Substances 0.000 abstract 1
- 231100000024 genotoxic Toxicity 0.000 abstract 1
- 230000001738 genotoxic effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261586087P | 2012-01-12 | 2012-01-12 | |
| PCT/US2013/020934 WO2013106506A1 (en) | 2012-01-12 | 2013-01-10 | Stabilized pharmaceutical formulations of a potent hcv inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ626353A true NZ626353A (en) | 2016-02-26 |
Family
ID=47628447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ626353A NZ626353A (en) | 2012-01-12 | 2013-01-10 | Stabilized pharmaceutical formulations of a potent hcv inhibitor |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20140037719A1 (index.php) |
| EP (1) | EP2802313A1 (index.php) |
| JP (1) | JP2015503616A (index.php) |
| KR (1) | KR20140109433A (index.php) |
| CN (1) | CN104244926A (index.php) |
| AP (1) | AP2014007760A0 (index.php) |
| AR (1) | AR089710A1 (index.php) |
| AU (1) | AU2013208024A1 (index.php) |
| BR (1) | BR112014017058A8 (index.php) |
| CA (1) | CA2861041A1 (index.php) |
| CL (1) | CL2014001783A1 (index.php) |
| CO (1) | CO7000774A2 (index.php) |
| EA (1) | EA201400808A1 (index.php) |
| EC (1) | ECSP14013104A (index.php) |
| HK (1) | HK1204982A1 (index.php) |
| IL (1) | IL233550A0 (index.php) |
| IN (1) | IN2014DN05759A (index.php) |
| MA (1) | MA35865B1 (index.php) |
| MX (1) | MX2014008205A (index.php) |
| NZ (1) | NZ626353A (index.php) |
| PE (1) | PE20141817A1 (index.php) |
| PH (1) | PH12014501598A1 (index.php) |
| SG (1) | SG11201404042VA (index.php) |
| TN (1) | TN2014000295A1 (index.php) |
| TW (1) | TW201340969A (index.php) |
| UY (1) | UY34569A (index.php) |
| WO (1) | WO2013106506A1 (index.php) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| WO2014145095A1 (en) | 2013-03-15 | 2014-09-18 | Gilead Sciences, Inc. | Macrocyclic and bicyclic inhibitors of hepatitis c virus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5329976A (en) * | 1991-12-09 | 1994-07-19 | Habley Medical Technology Corporation | Syringe-filling and medication mixing dispenser |
| US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| UY28240A1 (es) * | 2003-03-27 | 2004-11-08 | Boehringer Ingelheim Pharma | Fases cristalinas de un potente inhibidor de la hcv |
| EP1654261B1 (en) | 2003-05-21 | 2007-11-14 | Boehringer Ingelheim International GmbH | Hepatitis c inhibitor compounds |
| US7514557B2 (en) | 2004-05-25 | 2009-04-07 | Boehringer Ingelheim International Gmbh | Process for preparing acyclic HCV protease inhibitors |
| WO2006130552A2 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methods of treating hepatitis c virus |
| MY153093A (en) | 2008-09-16 | 2014-12-31 | Boehringer Ingelheim Int | Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor |
| UA105777C2 (uk) * | 2008-11-21 | 2014-06-25 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Фармацевтична композиція ефективного інгібітора вгс для перорального введення |
| KR101685941B1 (ko) | 2009-07-07 | 2016-12-13 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｃ형 간염 바이러스 프로테아제 억제제를 위한 약제학적 조성물 |
-
2013
- 2013-01-10 IN IN5759DEN2014 patent/IN2014DN05759A/en unknown
- 2013-01-10 AU AU2013208024A patent/AU2013208024A1/en not_active Abandoned
- 2013-01-10 AP AP2014007760A patent/AP2014007760A0/xx unknown
- 2013-01-10 EA EA201400808A patent/EA201400808A1/ru unknown
- 2013-01-10 HK HK15105856.5A patent/HK1204982A1/xx unknown
- 2013-01-10 MX MX2014008205A patent/MX2014008205A/es unknown
- 2013-01-10 SG SG11201404042VA patent/SG11201404042VA/en unknown
- 2013-01-10 US US13/738,057 patent/US20140037719A1/en not_active Abandoned
- 2013-01-10 NZ NZ626353A patent/NZ626353A/en not_active IP Right Cessation
- 2013-01-10 CA CA2861041A patent/CA2861041A1/en not_active Abandoned
- 2013-01-10 CN CN201380009046.3A patent/CN104244926A/zh active Pending
- 2013-01-10 WO PCT/US2013/020934 patent/WO2013106506A1/en not_active Ceased
- 2013-01-10 BR BR112014017058A patent/BR112014017058A8/pt not_active Application Discontinuation
- 2013-01-10 EP EP13701884.2A patent/EP2802313A1/en not_active Withdrawn
- 2013-01-10 JP JP2014552281A patent/JP2015503616A/ja active Pending
- 2013-01-10 PE PE2014001095A patent/PE20141817A1/es not_active Application Discontinuation
- 2013-01-10 KR KR1020147019404A patent/KR20140109433A/ko not_active Withdrawn
- 2013-01-11 AR ARP130100099A patent/AR089710A1/es unknown
- 2013-01-11 UY UY0001034569A patent/UY34569A/es unknown
- 2013-01-11 TW TW102101220A patent/TW201340969A/zh unknown
-
2014
- 2014-07-03 CL CL2014001783A patent/CL2014001783A1/es unknown
- 2014-07-07 TN TNP2014000295A patent/TN2014000295A1/fr unknown
- 2014-07-08 IL IL233550A patent/IL233550A0/en unknown
- 2014-07-08 CO CO14146892A patent/CO7000774A2/es unknown
- 2014-07-11 MA MA37207A patent/MA35865B1/fr unknown
- 2014-07-11 PH PH12014501598A patent/PH12014501598A1/en unknown
- 2014-08-08 EC ECIEPI201413104A patent/ECSP14013104A/es unknown
-
2015
- 2015-03-20 US US14/663,915 patent/US20150190458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PH12014501598A1 (en) | 2014-10-08 |
| BR112014017058A2 (pt) | 2017-06-13 |
| BR112014017058A8 (pt) | 2017-07-04 |
| CN104244926A (zh) | 2014-12-24 |
| US20140037719A1 (en) | 2014-02-06 |
| JP2015503616A (ja) | 2015-02-02 |
| AU2013208024A1 (en) | 2014-07-10 |
| US20150190458A1 (en) | 2015-07-09 |
| CO7000774A2 (es) | 2014-07-21 |
| EP2802313A1 (en) | 2014-11-19 |
| AP2014007760A0 (en) | 2014-07-31 |
| IN2014DN05759A (index.php) | 2015-04-10 |
| UY34569A (es) | 2013-07-31 |
| AR089710A1 (es) | 2014-09-10 |
| KR20140109433A (ko) | 2014-09-15 |
| CA2861041A1 (en) | 2013-07-18 |
| SG11201404042VA (en) | 2014-08-28 |
| MX2014008205A (es) | 2014-08-08 |
| CL2014001783A1 (es) | 2014-12-12 |
| EA201400808A1 (ru) | 2015-02-27 |
| TW201340969A (zh) | 2013-10-16 |
| PE20141817A1 (es) | 2014-12-17 |
| HK1204982A1 (en) | 2015-12-11 |
| ECSP14013104A (es) | 2015-11-30 |
| MA35865B1 (fr) | 2014-12-01 |
| TN2014000295A1 (en) | 2015-12-21 |
| IL233550A0 (en) | 2014-08-31 |
| WO2013106506A1 (en) | 2013-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550552A1 (en) | Inhibitors of hepatitis c virus | |
| HK1255102A1 (zh) | 杂环化合物及其应用 | |
| TN2017000529A1 (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| MX2017008518A (es) | Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih). | |
| MY190561A (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| GEP20156263B (en) | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof | |
| NZ703066A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| TN2014000155A1 (en) | Substituted tetrahydroisoquinoline compounds as factor xia inhibitors | |
| WO2012040389A3 (en) | Substituted bicyclic hcv inhibitors | |
| NZ721780A (en) | Heterocyclic modulators of lipid synthesis for use against cancer and viral infections | |
| SG11201600004SA (en) | Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same | |
| WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| MD20150053A2 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| MX2015013224A (es) | Inhibidores macrociclicos y biciclicos del virus de la hepatitis c. | |
| WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
| MX360161B (es) | Proceso para preparar compuestos antiviricos. | |
| MX2017015505A (es) | Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma. | |
| PH12014501598A1 (en) | Stabilized pharmaceutical formulations of a potent hcv inhibitor | |
| WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
| MY178515A (en) | Hcv inhibitory chemical compounds, pharmaceutical compositions and applications thereof | |
| WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
| HUP1300648A2 (hu) | Dabigatran és származékainak komplexei,elõállításuk és gyógyszerészeti kompozícióik | |
| HUP1400084A2 (hu) | Dabigatran és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói | |
| TH1301000018B (th) | รูปผลึกเดลตาของเกลืออาร์จินีน (arginine) ของเพอรินโดพริล (perindopril), กระบวนการสำหรับการเตรียมสารดังกล่าว และองค์ประกอบทางเภสัชกรรมที่มีสารดังกล่าว |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, DE Effective date: 20160225 |
|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |